02RS48Z
Replacement Pulmonary Vein, Right to No Qualifier with Zooplastic Tissue, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 2 Heart and Great Vessels |
| Operation | R Replacement |
| Body Part | S Pulmonary Vein, Right |
| Approach | 4 Percutaneous Endoscopic |
| Device | 8 Zooplastic Tissue |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically takes the place and/or function of all or a portion of a body part
Procedure Overview
Replacement procedures put in biological or synthetic material to physically take over for all or part of a heart valve, chamber wall, or great vessel segment that is diseased or damaged beyond simple repair. The most recognizable example is heart valve replacement, where a damaged aortic or mitral valve is taken out and substituted with a mechanical valve, a tissue valve from an animal or human donor, or, increasingly, a valve delivered through a catheter without open-heart surgery.
This family also includes replacing a diseased section of the aorta with a synthetic graft, as is done for an aneurysm or dissection. The underlying decision behind these procedures is that the native tissue can no longer perform its function safely, so a substitute structure is needed to physically stand in for it going forward.
Anatomy & Axis Detail
Pulmonary Vein, Right
The right pulmonary vein set returns oxygenated blood from the right lung to the left atrium and may require replacement when affected by pulmonary vein stenosis, a condition that can be congenital or arise after ablation procedures for atrial fibrillation. Because these veins are short and enter the atrium at variable angles, replacement is technically challenging and may involve patch or conduit techniques rather than simple end-to-end grafting. This procedure is more commonly performed in pediatric patients with congenital pulmonary vein stenosis than in adults. The documentation should reflect the specific material used to reconstruct the venous pathway, whether autologous pericardium, synthetic patch, or donor tissue, as this determines the applicable qualifier and distinguishes replacement from a lesser repair or dilation procedure.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Zooplastic Tissue
Zooplastic Tissue designates material of animal origin, most often bovine or porcine, used to replace or reinforce human anatomic structures such as heart valves or grafts. It is procured from a non-human source and processed for implantation, setting it apart from autologous tissue taken from the patient's own body and from nonautologous tissue sourced from another human donor.
Coding & Documentation
Coding a Replacement case requires documentation confirming that the native structure was taken out (or was already absent, as in a redo procedure) and that a device or graft material now physically occupies that role. The material matters for the device value assigned - mechanical valve, tissue valve, synthetic vascular graft, and autologous tissue graft are all coded differently, so the operative note must specify what was implanted. A common error is coding Replacement when a valve is repaired with an annuloplasty ring rather than fully replaced, since a ring supports the native valve rather than substituting for it, which belongs under Repair or Supplement. Another pitfall is missing that a transcatheter valve replacement still qualifies as Replacement despite the minimally invasive approach, since the root operation depends on what was done, not how the access was gained.